

No More Epidemics
Dr. Johan Van Hoof, Global Head of Janssen Vaccines, sat down for an on-camera interview with The Business Debate that has been posted on The Wall Street Journal. He spoke about Johnson & Johnson’s commitment to combat Ebola through Janssen’s vaccine development program, global partnerships and broader activities to promote pandemic preparedness.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
-
Did you like reading this story? Click the heart to show your love.
-
Did you like reading this story? Click the heart to show your love.